{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:26:41Z","timestamp":1792099601158,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Menlo Therapeutics Inc"},{"name":"Fresenius Medical Care"},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Janssen-Cilag"},{"name":"Mylan\/Meda"},{"name":"MSD"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wolff"},{"name":"Menlo Therapeutics Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jaad.2019.01.052","type":"journal-article","created":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T14:42:58Z","timestamp":1552833778000},"page":"1395-1402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"80","author":[{"given":"Sonja","family":"St\u00e4nder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Hirman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Weisshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.01.052_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jdv.14570","article-title":"European Academy of Dermatology and Venereology European Prurigo Project: expert consensus on the definition, classification and terminology of chronic prurigo","volume":"32","author":"Pereira","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.01.052_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ejp.767","article-title":"The pathogenesis of prurigo nodularis\u2013\u2018super-itch\u2019 in exploration","volume":"20","author":"Zeidler","year":"2016","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jaad.2019.01.052_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/09546634.2013.814759","article-title":"Prurigo nodularis: an update on etiopathogenesis and therapy","volume":"24","author":"Fostini","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2019.01.052_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2012.04481.x","article-title":"Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients","volume":"27","author":"Iking","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.01.052_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00128071-200405020-00003","article-title":"Prurigo: diagnosis and management","volume":"5","author":"Wallengren","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2019.01.052_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000358250","article-title":"Extensive prurigo nodularis: characterization and etiology","volume":"228","author":"Tan","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2019.01.052_bib7","first-page":"221","article-title":"Prurigo nodularis: picking the right treatment","volume":"64","author":"Saco","year":"2015","journal-title":"J Fam Pract"},{"key":"10.1016\/j.jaad.2019.01.052_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1440-0960.2005.00187.x","article-title":"Prurigo nodularis: a review","volume":"46","author":"Lee","year":"2005","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.052_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2340\/00015555-0305","article-title":"Clinical classification of itch: a position paper of the International Forum for the Study of Itch","volume":"87","author":"St\u00e4nder","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.01.052_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2340\/00015555-1949","article-title":"Facing the challenges of chronic pruritus: a report from a multi-disciplinary medical itch centre in Germany","volume":"95","author":"St\u00e4nder","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.01.052_bib11","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMcp1208814","article-title":"Clinical practice. Chronic pruritus","volume":"368","author":"Yosipovitch","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2019.01.052_bib12","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8659.1","article-title":"Advances in understanding itching and scratching: a new era of targeted treatments","volume":"5","author":"Sanders","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.jaad.2019.01.052_bib13","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.jid.5700231","article-title":"Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus","volume":"126","author":"Steinhoff","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.01.052_bib14","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0022-3565(24)37703-1","article-title":"Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice","volume":"286","author":"Andoh","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2019.01.052_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1152\/physrev.00031.2013","article-title":"Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease","volume":"94","author":"Steinhoff","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jaad.2019.01.052_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jdermsci.2010.03.020","article-title":"Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis","volume":"58","author":"Haas","year":"2010","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.052_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2340\/00015555-2780","article-title":"Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof-of-concept, controlled trial with topical aprepitant","volume":"98","author":"Ohanyan","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.052_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/14656566.2016.1127355","article-title":"Advances in therapeutic strategies for the treatment of pruritus","volume":"17","author":"Stull","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaad.2019.01.052_bib19","doi-asserted-by":"crossref","first-page":"e10968","DOI":"10.1371\/journal.pone.0010968","article-title":"Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy","volume":"5","author":"St\u00e4nder","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2019.01.052_bib20","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S1470-2045(12)70397-2","article-title":"Aprepitant for pruritus: drug-drug interactions matter","volume":"13","author":"Mir","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2019.01.052_bib21","series-title":"EMEND\u00ae (aprepitant) capsules","year":"2003"},{"key":"10.1016\/j.jaad.2019.01.052_bib22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.juro.2010.03.147","article-title":"A multicenter, double-blind, randomized, placebo controlled trial of a neurokinin-1 receptor antagonist for overactive bladder","volume":"184","author":"Frenkl","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.jaad.2019.01.052_bib23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-2602","article-title":"ItchApp: an app-based eDiary for assessment of chronic pruritus in clinical trials","volume":"97","author":"Gernart","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.01.052_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000446049","article-title":"Prurigo nodularis management","volume":"50","author":"Tsianakas","year":"2016","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.jaad.2019.01.052_bib25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaad.2018.02.030","article-title":"Serlopitant for the treatment of chronic pruritus: results of a randomized, multicenter, placebo-controlled phase 2 clinical trial","volume":"78","author":"Yosipovitch","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.052_bib26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2340\/00015555-2433","article-title":"Itch assessment with visual analogue scale and numerical rating scale: determination of minimal clinically important difference in chronic itch","volume":"96","author":"Reich","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.01.052_bib27","series-title":"Tradipitant improves worst itch and disease severity in patients with atopic dermatitis","first-page":"P067","author":"Heitman","year":"2018"},{"key":"10.1016\/j.jaad.2019.01.052_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/dth.12094","article-title":"Combination therapy of fexofenadine and montelukast is effective in prurigo nodularis and pemphigoid nodularis","volume":"27","author":"Shintani","year":"2014","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2019.01.052_bib30","first-page":"533","article-title":"Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases","volume":"41","author":"Metze","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.052_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1529-8019.2010.01314.x","article-title":"Therapeutic hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin","volume":"23","author":"Gencoglan","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2019.01.052_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jcpt.12005","article-title":"Treatment of prurigo nodularis with pregabalin","volume":"38","author":"Mazza","year":"2013","journal-title":"J Clin Pharm Ther"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219301616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219301616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:51:25Z","timestamp":1759272685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219301616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0190962219301616"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.052","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}